Holders over time
- CVS
- COST
| Quarter | CVS | COST |
|---|---|---|
| Q3 2020 | 29 holders, $8.9bn | 32 holders, $15.4bn |
| Q4 2020 | 22 holders, $9.8bn | 30 holders, $15.3bn |
| Q1 2021 | 28 holders, $10.3bn | 29 holders, $13.4bn |
| Q2 2021 | 24 holders, $11.8bn | 25 holders, $15.5bn |
| Q3 2021 | 28 holders, $11.9bn | 25 holders, $16.9bn |
| Q4 2021 | 28 holders, $14.7bn | 27 holders, $20.5bn |
| Q1 2022 | 25 holders, $14.4bn | 32 holders, $19.9bn |
| Q2 2022 | 30 holders, $13.5bn | 30 holders, $15.8bn |
| Q3 2022 | 28 holders, $13.9bn | 33 holders, $16.0bn |
| Q4 2022 | 30 holders, $12.6bn | 33 holders, $32.7bn |
| Q1 2023 | 36 holders, $9.6bn | 29 holders, $14.9bn |
| Q2 2023 | 33 holders, $9.8bn | 37 holders, $16.0bn |
| Q3 2023 | 33 holders, $11.7bn | 30 holders, $16.8bn |
| Q4 2023 | 32 holders, $14.2bn | 26 holders, $20.1bn |
| Q1 2024 | 21 holders, $14.3bn | 29 holders, $21.5bn |
| Q2 2024 | 24 holders, $14.2bn | 31 holders, $24.7bn |
| Q3 2024 | 31 holders, $14.2bn | 28 holders, $24.7bn |
| Q4 2024 | 32 holders, $11.0bn | 34 holders, $26.0bn |
| Q1 2025 | 29 holders, $19.1bn | 35 holders, $28.2bn |
| Q2 2025 | 31 holders, $19.6bn | 36 holders, $29.4bn |
| Q3 2025 | 28 holders, $21.9bn | 35 holders, $26.7bn |
| Q4 2025 | 29 holders, $22.8bn | 40 holders, $34.6bn |
| Q1 2026 | 32 holders, $21.1bn | 40 holders, $36.1bn |
| Q2 2026 | 31 holders, $30.8bn | 38 holders, $35.5bn |
CVS Health Corp
- Holders
- 31
- Reported value
- $14.2bn
- Buyers
- 23
- Sellers
- 10
Breadth +13 among 94 comparable managers.
Costco Wholesale Corporation
- Holders
- 28
- Reported value
- $24.7bn
- Buyers
- 15
- Sellers
- 13
Breadth +2 among 94 comparable managers.
Who holds both, Q3 2024
Both (17)
AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Balyasny Asset Management LLC, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, D. E. Shaw & Co., Fidelity (FMR LLC), GAMCO Investors Inc, Invesco Ltd, Janus Henderson Group Ltd, Millennium Management LLC, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Two Sigma Advisers LP, Two Sigma Investments LP
Only CVS (14)
Caxton Associates LLP, Dodge & Cox, Eisler Capital Management Ltd, Glenview Capital Management LLC, Harris Associates LP, Marshall Wace LLP, Point72 Asset Management LP, Quantbot Technologies LP, Renaissance Technologies LLC, Sachem Head Capital Management LP, Schonfeld Strategic Advisors LLC, Third Point LLC, Tudor Investment Corp, Voloridge Investment Management LLC
Only COST (11)
Acadian Asset Management LLC, Brevan Howard Capital Management LP, ExodusPoint Capital Management LP, Man Group PLC, Markel Group Inc, Maverick Capital Ltd, MFS Investment Management, Neuberger Berman Group LLC, Susquehanna International Group LLP, Walleye Capital LLC, Wellington Management Group LLP
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.